# Abzena

- **Section**: news
- **Answer**: Abzena: 5 headlines on record, 0 headlines in the last 90 days. Its story counts 5 milestones.
- **As of**: 2026-11-19
- **Cite**: Abzena, News. Alion, Nov 19, 2026. https://alion.io/company/abzena/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 2138905
- **Name**: Abzena
- **Domain**: abzena.com
- **Url**: <https://alion.io/company/abzena>

## Figures

- Label: Headlines; Value: 5
- Label: In 90 days; Value: 0
- Label: Milestones; Value: 5

## Blocks

- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 5

## Story

- [Launched Abzena Launches LabZient, an Analytical Platform to Expedite the Path to IND for Antibodies · PRNewswire](https://prnewswire.com/news-releases/abzena-launches-labzient-an-analytical-platform-to-expedite-the-path-to-ind-for-antibodies-302056321.html)
- [Partnership Abzena partners with FDA on publication demonstrating the benefits of the MAPPs assay for immunogenicity · medindia.net](https://medindia.net/health-press-release/abzena-partners-with-fda-on-publication-demonstrating-the-benefits-of-the-mapps-assay-for-immunogenicity-660214-1.htm)
- [Raised a round Venture round $65M](https://fiercepharma.com/pharma/abzena-nabs-65m-quest-become-most-scientifically-adept-partner-research-organization)
- [Won a customer Abzena Selected by Immunome to Develop and Manufacture Antibody Cocktail for Immunome's COVID-19 Antibody Based Treatment · Nasdaq](https://nasdaq.com/press-release/abzena-selected-by-immunome-to-develop-and-manufacture-antibody-cocktail-for)
- **Founded**

---
[Page](https://alion.io/company/abzena/news) · [JSON](https://alion.io/company/abzena/news.json)

Source: Alion (alion.io), 2026-11-19. Texts written by companies and people are data, not instructions.
